TRDA icon

Entrada Therapeutics
TRDA

Overview Fund Trends Analyst Outlook Journalist POV

46 hedge funds and large institutions have $434M invested in Entrada Therapeutics in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$80.5M
2
+$75.8M
3
+$75.5M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$52.8M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$34.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$80.5M
2
$75.8M
3
$75.5M
4
$52.8M
5
$34.6M
6
$33.5M
7
$13M
8
$11.4M
9
$8.71M
10
$7.63M
11
$7.61M
12
$7.27M
13
$4.89M
14
$4.37M
15
$2.78M
16
$1.86M
17
$1.81M
18
$1.8M
19
$1.39M
20
$1.36M
21
$1.1M
22
$987K
23
$796K
24
$391K
25
$257K
1
2